Document is current
Any future updates will be listed below
-
Authors
Drouin, Arnaud
Plumb, Ian D.
McCullough, Matthew
James Gist, Jade
Liu, Sharon
Theberge, Marc
Katz, Joshua
Moreida, Matthew
Flaherty, Shelby
Chatwani, Bhoomija
Briggs Hagen, Melissa
Midgley, Claire M.
Fusco, Dahlene
-
Funding
Funding for this research was provided by:
Centers for Disease Control and Prevention (U01CK000480)
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 17 March 2024
First Online: 19 March 2024
Competing interests
: DF has served on an Advisory Board for Gilead Sciences and for AXCELLA, and as site PI for clinical trials sponsored by Gilead Sciences, Regeneron, MetroBiotech LLC, and the NIH (DMID COVAIL). AD has served as co site-PI on clinical trials sponsored by Gilead Sciences, Regeneron, MetroBiotech LLC, and the NIH (DMID COVAIL). Other authors declare that they have no conflict of interest.
